NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

From what I understand, an outsider to the company, such as LL, who is the Principal Investigator for the trial, can talk to the P3 data in a scientific conference.

If she talks about material undisclosed information then that is a Reg FD issue. Does not matter at all if she is insider or not. Would apply if she was just an unrelated party who found the information on a printer/copier.

If she talks about it w/o NWBO knowing then it is unintentional, and NWBO has to properly disclose ASAP. If NWBO knows that she is doing it then it must be disclosed in advance.

Given that NWBO already PR'd more than what had already been disclosed, have to assume they know what LP is talking about and an advance (or concurrent) proper disclosure of any material information would be required.

Now, if she wants to present the same old regurgitated info on the trial, that is fine.